ArticleCureus2026
Hereditary Hemolytic Spherocytosis in the Active-Duty Population: A Unique Case.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hereditary spherocytosis (HS) is a common inherited cause of hemolytic anemia and is most often diagnosed in childhood. While the condition does not by itself disqualify affected adults from military service, its autosomal dominant inheritance has important implications for offspring, who may develop more severe disease. We report the case of a 38-year-old active-duty US Army soldier of Saipanese (Chamorro) descent who presented with persistent, unexplained fatigue -- most pronounced during strenuous physical activity -- despite adequate sleep. He had no formal family history of anemia, although one of his three children carries an undiagnosed anemia. Physical examination revealed splenomegaly. Laboratory evaluation demonstrated compensated hemolysis, as evidenced by a low-normal hemoglobin maintained by a reticulocyte response of 9.36%, a normal mean corpuscular volume, an elevated mean corpuscular hemoglobin concentration of 36.7 g/dL -- a characteristic diagnostic feature of HS -- an elevated red cell distribution width, undetectable haptoglobin, and elevated lactate dehydrogenase and indirect bilirubin. The peripheral blood smear was reported by the staff pathologist as a normocytic, normochromic anemia with occasional spherocyte-like forms and mild polychromasia. The patient also demonstrated mild-to-moderate hepatic iron overload despite the absence of transfusions. Genetic testing identified a heterozygous nonsense mutation in the
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.